Promis Financial Statements From 2010 to 2026

Promis Neurosciences Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 22.8 M 21.7 M 7.2 M Slightly volatile Total Current Liabilities 3.2 M 2.6 M 2.2 M Slightly volatile Accounts Payable 1.9 M 2 M 1.4 M Slightly volatile Cash 16 M 15.3 M 5.7 M Slightly volatile Net Receivables 59.1 K 70.9 K 53.8 K Slightly volatile Short Term Investments 30.8 K 29.7 K 38.5 K Slightly volatile Other Stockholder Equity 7.1 M 10.2 M 5.4 M Slightly volatile Total Liabilities 5.3 M 2.8 M 3.3 M Slightly volatile Short and Long Term Debt 96.7 K 108.8 K 118.7 K Slightly volatile Total Current Assets 22.8 M 21.7 M 7.1 M Slightly volatile Intangible Assets 44 K 37.5 K 54.9 K Slightly volatile Common Stock 53 M 82.9 M 49.3 M Slightly volatile Property Plant Equipment 6.5 K 6.8 K 14.9 K Pretty Stable Common Stock Shares Outstanding 1.1 M 1.2 M 177 M Slightly volatile Other Current Liabilities 503 K 565.9 K 617.7 K Slightly volatile Other Liabilities 7.1 M 8 M 8.7 M Slightly volatile Long Term Debt 4 M 4.4 M 4.9 M Slightly volatile Other Current Assets 30.3 K 54.4 K 27.6 K Slightly volatile Property Plant And Equipment Gross 65.8 K 72.3 K 81.6 K Slightly volatile
Promis Neurosciences Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Selling General Administrative 4.4 M 7.1 M 3.3 M Slightly volatile Research Development 7.6 M 12.2 M 5.5 M Slightly volatile Total Operating Expenses 11.9 M 19.4 M 8.8 M Slightly volatile Interest Income 4.8 K 5.4 K 5.9 K Slightly volatile
Promis Neurosciences Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Total Cash From Financing Activities 33.7 M 32.1 M 11.3 M Slightly volatile End Period Cash Flow 16 M 15.3 M 5.7 M Slightly volatile Change To Netincome 881.5 K 1.6 M 881.8 K Slightly volatile Begin Period Cash Flow 15.2 M 14.5 M 4.6 M Slightly volatile Stock Based Compensation 577.7 K 949.7 K 547.1 K Slightly volatile Other Non Cash Items 4.3 M 4.1 M 1.2 M Slightly volatile

About Promis Neurosciences Financial Statements

Currently Active Assets on Macroaxis

When determining whether Promis Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Promis Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:

How To Invest In Promis Details

Is Promis Stock a good investment? Details

What is Promis Neurosciences' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Intrinsic Valuation Details

Financial Analysis Details

Buy or Sell Advice Details

Technical Analysis Details

Understanding that Promis Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Promis Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Promis Neurosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.